Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

The World Health Organization (WHO) yesterday released a roadmap to address rising resistance to treatments for HIV, ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

A new UNAIDS report reveals that major funding cuts have led to service disruptions for those living with HIV, contributing ...

Dramatic international funding cuts have thrown the global HIV response into turmoil, the United Nations said Tuesday, ...

Millions of people, particularly in African countries, have lost access to drug treatments, prevention and testing putting ...

GENEVA (Reuters) -People living with HIV have died due to service disruptions caused by major funding cuts, while millions of ...

New HIV infections among gay and bisexual men in the United States have fallen over the past few years, in part due to earlier and more widespread use of effective antiretroviral therapy, according to ...

A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has ...

Vietnam is seeing a sharp shift in HIV transmission, with most new infections now occurring through sexual contact, ...